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All characterized orthoreoviruses encode a characteristic spike-like protein on their polycistronic S1 genome segments
that mediates virus cell attachment. In the case of baboon reovirus (BRV), the polycistronic S-class genome segment
corresponds to the smallest S4 segment. We recently determined that the 5-proximal open reading frame (ORF) of the
bicistronic S4 segment encodes a nonstructural protein responsible for virus-induced syncytium formation. Current analysis
indicates that the p16 protein encoded by the 3-proximal ORF of the BRV S4 genome segment shows no sequence similarity
to any other protein encoded by the orthoreoviruses, including the well-characterized 1/C reovirus cell attachment protein.
Results indicate that p16 is a BRV-specific nonstructural protein that is not required for virus infection in cell culture and is
not involved in viral cell attachment. In conjunction with previous studies of the BRV S1, S2, and S3 genome segments, the
current results indicate that, unlike all other orthoreoviruses, BRV does not encode a cell attachment protein in its S-classy studi
in to mINTRODUCTION
Receptor binding represents an early essential event
in the virus replication cycle. The specificity and avidity
of such virus–cell interactions have profound effects on
virus tissue tropism, host range, and pathogenicity. In the
case of the nonenveloped orthoreoviruses, a minor outer
capsid protein located at the vertices of the icosahedral
virus particle facilitates virus cell attachment (Lee et al.,
1981; Pacitti and Gentsch, 1987; Masri et al., 1986; Lee
and Leone, 1994). Genetic studies indicate that the S1
genome segment of mammalian reovirus (MRV), which is
bicistronic and encodes the 1 cell attachment protein,
plays a significant role in the pathogenic potential and
tissue tropism of the different MRV serotypes (Kaufman
et al., 1983; Sharpe and Fields, 1985; Tyler et al., 1986;
Nibert et al., 1995; Morin et al., 1996).
Recently, a novel reovirus was isolated from brain
tissue of a baboon suffering from meningoencephalomy-
elitis (Duncan et al., 1995; Leland et al., 2000). Extensive
sequence divergence and limited antigenic similarity be-
tween baboon reovirus (BRV) and the prototype MRVs
contributed to the designation of BRV as a distinct spe-
cies of orthoreovirus (Duncan, 1999). Unlike MRV, BRV is
potentially pathogenic in nonhuman primates (Leland et
al., 2000). The identification of the BRV cell attachment
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44protein and the association of this protein with BRV
pathogenesis has not been determined.
The orthoreoviruses are an unusual example of non-
enveloped viruses that utilize a spike protein to mediate
cell attachment (Lee et al., 1981; Furlong et al., 1988). The
trimeric MRV 1 protein contains a long fibrous tail
topped by a compact globular head (Furlong et al., 1988;
Strong et al., 1991; Duncan et al., 1991; Lee and Gilmore,
1998). An extended heptad repeat region that encom-
passes the amino-terminal one-third of the protein is
conserved in the 1 proteins of all mammalian reovi-
ruses (Duncan et al., 1990; Nibert et al., 1990) and in the
homologous C proteins of avian reovirus (ARV) and
Nelson Bay reovirus (NBV) (Shapouri et al., 1995, 1996;
Martinez-Costas et al., 1997; Grande et al., 2000; Shmu-
levitz et al., 2002). This heptad repeat is a hallmark
feature of the reovirus cell attachment proteins and con-
tributes to the formation and stability of a coiled coil
responsible for the generation of the functional trimeric
form of the 1 protein (Leone et al., 1991a,b, 1992; Gil-
more et al., 1996).
Previous analysis detected clear sequence conserva-
tion between the BRV S1, S2, and S3 genome segment-
encoded polypeptides and the MRV major -class core,
outer capsid, and nonstructural proteins, respectively,
indicating the homologous nature of these proteins (Dun-
can, 1999). Consequently, unlike all previously character-
ized reoviruses, BRV does not encode a homolog of
1/C in its S1 genome segment. The S4 genome seg-genome segments. Furthermore, cell binding and infectivit
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ment of BRV was recently shown to be functionally bi-
cistronic, encoding a p15 protein that is responsible for
the unusual syncytium-inducing ability of this nonenvel-
oped virus, and an uncharacterized p16 protein from a
second 3-proximal open reading frame (ORF) (Dawe
and Duncan, 2002). Since the cell attachment proteins of
the other orthoreoviruses are all encoded by polycis-
tronic S-class genome segments, and since none of the
other S-class genome segments of BRV encode a cell
attachment protein homolog, we investigated whether
the only uncharacterized BRV -class protein, the p16
gene product of the second S4 ORF, was responsible for
viral cell attachment. Results indicate that p16 is a BRV-
specific nonstructural protein that is not required for
virus infection in cell culture. It would appear that the
means by which BRV interacts with receptors to promote
endocytic uptake may be quite distinct from the 1/C
paradigm established for all other reoviruses.
RESULTS
The p16 protein is not a 1/C homolog
Sequence comparisons previously revealed that the
BRV S1, S2, and S3 genome segments are monocistronic
and do not encode a reovirus cell attachment protein
homolog (Duncan, 1999). Recent sequence analysis of
BRV S4 identified two partially overlapping ORFs of 140–
141 amino acids, both of which are functional (Fig. 1A)
(Dawe and Duncan, 2002). Since all characterized or-
thoreoviruses encode their cell attachment protein on
the polycistronic S-class genome segment, we predicted
that one of the ORFs on the bicistronic S4 genome
segment of BRV would encode a receptor-binding pro-
tein. The p15 gene product of the 5-proximal ORF was
shown to be responsible for BRV-induced syncytium for-
mation and as a nonstructural protein, not involved in
BRV cell attachment (Dawe and Duncan, 2002). We there-
fore sought to characterize the p16 gene product of the
3-proximal S4 ORF and to determine whether it medi-
ates BRV receptor interactions.
The predicted sequence of p16 was examined for
sequence similarity to the 1/C proteins of the other
orthoreoviruses. Although p16 is considerably smaller
than the typical reovirus cell attachment proteins (molec-
ular mass of 16,854 D), it might represent a truncated
1/C homolog. However, p16 displayed no significant
sequence similarity to 1/C. More importantly, the hep-
tad repeat structure that is characteristic of the reovirus
cell attachment proteins is absent in p16. Correspond-
ingly, the Coils (Lupas et al., 1991), Paircoils (Berger et al.,
1995), and MultiCoil (Wolf et al., 1997) algorithms failed to
detect a coiled coil motif in p16 (data not shown). These
results indicated that p16 is not a homolog of the typical
reovirus cell attachment protein.
The BRV p16 protein associates with virus particles
Although p16 did not appear to be a homolog of the
1/C protein, it was conceivable that it might represent
a novel reovirus receptor-binding protein. If so, then p16
should be a structural component of the virus. Radiola-
beled BRV particles were isolated from virus-infected cell
lysates by differential centrifugation and examined for
the presence of p16 using p16-specific antiserum. Con-
centrated virus preparations revealed the characteristic
reovirus protein profile with the major -, -, and -class
proteins in addition to an approximately 15–16 kDa
polypeptide (Fig. 1B). Immune precipitation with previ-
ously generated antisera specific for p15 or p16 (Dawe
and Duncan, 2002) demonstrated that the small virion-
associated protein was p16 (Fig. 1B, lane 4). The particle-
associated nature of p16 was consistent with a possible
role in promoting virus attachment to cells.
Anti-BRV and anti-p16 sera fail to inhibit BRV infection
To further address whether BRV p16 might function as
a novel reovirus cell attachment protein, we investigated
the ability of antiserum to inhibit the entry of BRV into
host cells in a plaque-reduction assay. Prior to infection
of Vero cell monolayers, the BRV inoculum was preincu-
bated with either anti-p16 serum or with baboon serum
obtained from animals naturally infected with BRV (Le-
FIG. 1. BRV p16 is particle associated. (A) Schematic representation
of the bicistronic BRV S4 genome segment encoding the p15 and p16
proteins. Numbers refer to nucleotide positions. The first and last
nucleotides (minus the termination codon) of the p15 and p16 open
reading frames are indicated. (B) The protein profiles of concentrated,
radiolabeled BRV particles were resolved by SDS–PAGE (15% acryl-
amide) without prior immune precipitation (), or after particle disrup-
tion by treatment with SDS or followed by immune precipitation with
normal rabbit serum (N), anti-p15 serum (15), or anti-p16 serum (16).
Protein bands were detected by fluorography. The positions of the -,
-, and -class reovirus proteins are shown at the left and the migra-
tion of molecular mass standards are indicated on the right.
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land et al., 2000). Compared to normal rabbit serum,
neither anti-p16 serum nor anti-BRV serum significantly
reduced the number of plaques produced by BRV in Vero
cells (Fig. 2A). The ability of these antisera to recognize
BRV structural proteins was confirmed by immune pre-
cipitation of virus-infected cell lysates. As shown in Fig.
2B, although the baboon sera recognized the major -,
-, and -class viral proteins, none of the sera recog-
nized p16. The inability of these sera to neutralize BRV
infectivity could not, therefore, be interpreted as evi-
dence against p16 functioning as the BRV receptor-bind-
ing protein. Although anti-p16 serum strongly reacts with
soluble p16 (Fig. 2B, lane 9), its failure to inhibit BRV
infection could have reflected an inability to recognize
p16 in the context of the BRV virion.
Soluble BRV p16 does not bind cells
The conserved heptad repeat that serves to stabilize
the functional trimeric form of the reovirus 1/C cell
attachment protein also imparts to the protein its ability
to bind to receptors in a virion-independent manner
(Yeung et al., 1989; Duncan et al., 1991; Shapouri et al.,
1996; Martinez-Costas et al., 1997). We therefore exam-
ined whether soluble p16 or any other BRV-encoded
gene product could bind to susceptible host cells. As
previously demonstrated, soluble MRV-3 1 derived by in
vitro translation exhibited cell-binding activity (Fig. 3,
lanes 5 and 6) and served as a positive control for the
binding assay. Under similar assay conditions, soluble
BRV p16 did not bind to susceptible cell monolayers. This
observation applied to p16 derived by in vitro translation
(Fig. 3, lanes 7 and 8) and to p16 present in the soluble
S100 fraction of BRV-infected cell lysates (Fig. 3, lanes 1
and 2). Binding was noted for an approximately 38-kDa
protein present in the BRV S100 fraction (Fig. 3, lane 2).
This binding, however, was determined to be nonspecific
adherence to cells by the major nonstructural protein
NS, as indicated by a similar cell-binding activity for
NS generated by in vitro translation of the BRV S2
genome segment (Fig. 3, lanes 3 and 4). The fact that
NS cell binding is not biologically significant in regard
to BRV infection was confirmed using virus particles
depleted of NS (see Figs. 4 and 5).
BRV p16 is not required for virus infectivity
The particle-associated nature of p16 lead us to sus-
pect that p16 might be involved in BRV cell attachment.
Since BRV particles appear to be unstable in CsCl gra-
dients (data not shown), we used differential centrifuga-
tion to obtain partially purified BRV particles. Although
p16 was present in such preparations of concentrated
BRV, the virus particles were also contaminated with the
BRV major nonstructural protein NS which appears to
adhere both to cell monolayers and to virions (Fig. 3). The
FIG. 2. Antisera do not inhibit BRV infectivity. (A) BRV inocula were
preincubated with normal rabbit serum (N), anti-BRV serum (BRV), or
anti-p16 serum (16) prior to infection of Vero cells. The infectivity of the
samples was then assayed in a plaque reduction assay. The results
shown are the mean plus/minus the standard error from triplicate
samples and are representative of five separate experiments. (B) Ra-
diolabeled BRV-infected cell lysates (INF) were immune precipitated
with a panel of baboon sera samples (1–6), normal rabbit serum (N), or
anti-p16 serum (16). Precipitates were resolved by SDS–PAGE and
detected by fluorography. The positions of the -, -, and -class
reovirus proteins are shown at the left and the migration of molecular
mass standards are indicated on the right.
FIG. 3. Soluble p16 does not bind to Vero cell monolayers. The
radiolabeled S100 fraction of a BRV-infected cell lysate, and in vitro
translated BRV NS, MRV 1, and BRV p16 were analyzed by SDS–
PAGE and fluorography prior to (unbound fraction, U) and following
(bound fraction, B) incubation with Vero cell monolayers. The positions
of the -, -, and -class reovirus proteins are shown at left and the
migration of molecular mass standards are indicated on the right.
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contamination of concentrated MRV preparations by
NS has been previously described (Huismans and Jok-
lik, 1976). The presence of a known nonstructural protein
in concentrated preparations of BRV particles suggested
that p16 may not be a structural protein of the virus but
merely particle-associated. We therefore determined pu-
rification conditions that would remove p16 and/or NS
from virus particles and assessed the infectivity of such
virus particles.
Treatment of MRV preparations with nonionic deter-
gent and RNase A was previously shown to remove
contaminating NS (Huissmans and Joklik, 1976). Similar
treatment of concentrated BRV particles with 1% Triton
X-100 plus 50 g/mL RNase A followed by recentrifuga-
tion of BRV particles through sucrose cushions removed
the vast majority (95%) of NS, but only approximately
60% of p16 (Fig. 4A, lane 2, and Fig. 4B). Extraction of BRV
preparations with freon removed over 98% of BRV-asso-
ciated NS and essentially all of the particle-associated
p16 (Fig. 4A, lane 3). Since the removal of p16 from BRV
did not disrupt the integrity of the BRV virion (freon-
extracted virus particles could be harvested after recen-
trifugation through sucrose), p16 must be only peripher-
ally associated with virus particles.
Contaminating cellular nucleic acids precluded quan-
tification of concentrated BRV virion preparations by
spectrophotometry; therefore, radiolabeled virus prepa-
rations (untreated, as well as those extracted with either
detergent and RNase or freon) were titered by densito-
metric analysis. Multiple exposures and twofold dilutions
of the virus preparations to ensure the fluorograms were
in the linear exposure range permitted standardizing BRV
particles to within a twofold concentration range. Two-
fold dilutions of the standardized BRV particle prepara-
tions were used to infect Vero cells and the numbers of
infectious foci were quantified by immunostaining. As
expected, removal of NS (detergent and RNase extrac-
tion) did not decrease the infectivity of BRV (Fig. 5). In
fact, removal of NS led to a slight, reproducible in-
crease in the per-particle infectivity of BRV as compared
to the untreated BRV sample, suggesting that particle-
associated NS actually interferes with BRV infection
rather than serving an essential function in BRV cell
attachment. More importantly, essentially complete re-
moval of particle-associated p16 by freon extraction had
no significant effect on BRV infectivity. These results
conclusively demonstrated that p16 does not function to
mediate BRV cell attachment and suggested that p16 is
a nonstructural protein.
FIG. 5. The p16 protein is not required for BRV infectivity. (A) Unin-
fected Vero cells (a) and cells infected with concentrated BRV particles
(b), or BRV particles extracted with Triton X-100 (c) or freon (d), were
stained using anti-p15 serum and alkaline phosphatase-conjugated
secondary antibody. (B) The average number of foci per field was
quantified over five random fields and presented as the mean plus/
minus standard error of duplicate samples. Untreated (—), Triton
X-100-extracted (TX), and freon extracted (FR) BRV.
FIG. 4. The p16 and NS proteins can be removed from BRV parti-
cles. (A) Concentrated radiolabeled BRV preparations (—) were sub-
jected to further extraction with either Triton X-100 (TX) or freon (FR) and
the protein profiles of the different particle preparations were resolved
by SDS–PAGE and detected by fluorography. (B) Relative percentage
protein (p16 or NS) content of untreated (—), Triton X-100-extracted
(TX), and freon-extracted (FR) BRV, quantified using densitometric anal-
ysis.
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BRV uses an endocytic entry pathway
The absence of a cell attachment protein among the
S-class genome segment gene products and the inability
to detect a 1/C equivalent that functions in a soluble
form to bind cell receptors raised the question of
whether BRV uses a receptor-mediated endocytosis
pathway to infect cells. To address this issue, we exam-
ined the effect of the endocytic inhibitor dansylcadaver-
ine on BRV infection (Davies et al., 1984). Treatment of
cells with dansylcadaverine during the virus entry phase
resulted in the complete inhibition of BRV-induced syn-
cytium formation and led to a 90% inhibition in virus
yield (Fig. 6). These results indicated that BRV utilizes an
endocytic entry pathway.
DISCUSSION
BRV does not encode a 1/C homolog in its S-class
genome segments
The role of the MRV 1 receptor-binding protein in
serotype-specific differences in tissue tropism and
pathogenesis has been amply demonstrated (Kaufman
et al., 1983; Tyler et al., 1986; Morin et al., 1996; Nibert et
al., 1995; Connolly et al., 2001). Additional studies have
revealed the importance of a conserved heptad repeat
sequence on protein folding and the formation of the
functional trimeric form of the MRV 1 protein (Leone et
al., 1991a, 1992; Lee and Leone, 1994; Lee and Gilmore,
1998; Gilmore et al., 1996). This characteristic heptad
repeat sequence is conserved in the C proteins of ARV
and NBV despite extensive deletions in the head and
neck regions of these smaller reovirus cell attachment
proteins (the C and 1 proteins are approximately 325
versus 455 residues, respectively) (Shmulevitz et al.,
2002). We have recently determined that a syncytium-
inducing reptilian reovirus represents a fifth species of
orthoreovirus that encodes a C homolog containing the
conserved heptad repeat region on its bicistronic S1
genome segment (R. Duncan, unpublished data). This
characteristic trimeric cell attachment protein encoded
by the polycistronic S1 genome segment is, therefore, a
hallmark feature of the orthoreoviruses.
The current data indicate that BRV is the only orthoreo-
virus that does not encode a 1/C homolog on its
polycistronic S-class genome segment. The bicistronic
S4 genome segment of BRV encodes two nonstructural
proteins that are not involved in virus entry. The product
of the first ORF, p15, is a nonstructural protein of the virus
and is responsible for the unusual syncytium-inducing
property of BRV (Dawe and Duncan, 2002). As we have
now shown, the p16 product of the second S4 ORF does
not contain the characteristic heptad repeat structure of
1/C, it displays no soluble cell-binding capability, and
it is not required for BRV infectivity. Consequently, BRV
represents the only example of an orthoreovirus that
does not encode a homolog of the 1/C cell attachment
protein in its S-class genome segments.
It is also possible that none of the BRV-encoded gene
products represent a 1/C equivalent. Although sequence
information is not available for the three L-class and three
M-class genome segments of BRV, these segments are in
the same size range as the corresponding genome seg-
ments of the other orthoreoviruses (Duncan et al., 1995;
Duncan, 1999). Furthermore, these genome segments en-
code  and  proteins with similar molecular masses as
the corresponding proteins of the other reoviruses. Since
the open reading frames encoding the reovirus  and 
proteins extend for almost the complete length of the ge-
nome segment encoding each protein (Bruen et al., 2001), it
is unlikely that a homolog of the reovirus 1/C cell attach-
ment protein could be encoded by an additional 1000–1600
FIG. 6. BRV utilizes an endocytic entry pathway. (A) BRV-infected Vero
cells infected in the absence (a) or presence (b) of the endocytic
inhibitor dansylcadaverine were fixed and Giemsa-stained at 12-h
postinfection to reveal the ability of the inhibitor to reduce virus infec-
tion and virus-induced syncytium formation. (B) Vero cells were infected
with BRV in the presence or absence of dansylcadaverine during the
virus attachment and entry phase. Infected cell cultures were incu-
bated for 72 h and the progeny virus yield was determined by plaque
assay. Results are presented as the average  standard error of
duplicate experiments performed in triplicate.
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nucleotide ORF present in any of the L-class or M-class
genome segments of BRV. This supposition is supported by
the fact that the protein profile of infectious BRV particle
preparations contains the standard repertoire of , , and 
proteins with no evidence of an additional protein that
might represent the 1/C cell attachment protein (Fig. 4).
The cell-binding results (Fig. 3) provided more compel-
ling evidence that BRV does not encode a 1/C homolog
in its genome. Other than the nonspecific cell adherence
displayed by NS, no soluble protein present in the S100
fraction from BRV-infected cells displayed any cell-binding
capability. Even though the ARV and MRV 1/C proteins
share almost no sequence identity, an N-proximal heptad
repeat structure stabilizes the trimeric form of both proteins
which function in a soluble form to bind cell receptors. The
absence of such cell-binding activity by any of the soluble
BRV proteins present in virus-infected cell lysates suggests
BRV may not encode a 1/C homolog, at least as far as
the ability of such a protein to function in a soluble, non-
virion-associated form.
The cell-binding capability of NS has no biological rel-
evance to virus cell attachment since removal of virion-
associated NS actually enhanced, rather than inhibited,
virus infectivity (Figs. 4 and 5). The MRV NS protein asso-
ciates with cytoskeleton, it binds ssRNA in a sequence-
independent manner, and it has been implicated in RNA
replication and packaging (Antczak and Joklik, 1992; Huis-
mans and Joklik, 1976; Mora et al., 1987; Gillian et al., 2000).
The BRV NS protein also associates with concentrated
virus particles (Fig. 4). Apparently, the reovirus NS protein
possesses the ability to interact with numerous macromo-
lecular structures, a property that may contribute to the
nonspecific association of the protein with cell monolayers.
The p16 protein is a BRV-specific nonstructural
protein
The fact that BRV particles devoid of p16 were fully
infectious (Figs. 4 and 5) conclusively demonstrated that
p16 is not required for BRV infectivity and implied that p16
is a nonstructural protein. Whether the association of p16
with concentrated BRV preparations is biologically relevant,
reflecting an affinity of p16 for capsid proteins, or repre-
sents nonspecific protein association is not clear.
Other than virus particle association, no other biolog-
ical properties are known for the BRV p16 protein that
would facilitate speculation as to the role of this protein
in the virus-replication cycle. The p16 protein is acidic
(pI  4.53) and lacks any identifiable structural or func-
tional motifs. Direct sequence comparisons revealed no
obvious sequence similarity to any other small nonstruc-
tural proteins encoded by the orthoreoviruses or by other
members of the family Reoviridae. This included the
small, basic, nonstructural proteins encoded by other
orthoreovirus polycistronic S-class genome segments
that display no conservation of similar amino acids as
indicated by their distinct hydropathy profiles (data not
shown). The BRV-specific nature of p16 (i.e., other or-
thoreoviruses do not encode this protein) suggests this
is an accessory protein of the virus that is not essential
for virus replication in cell culture, similar to the situation
with the 1NS protein of MRV (Rodgers et al., 1998).
BRV receptor interactions in the absence of a
prototypical reovirus cell attachment protein
Although BRV appears to utilize a receptor-mediated
endocytic entry pathway (as evident by the inhibition of
virus infection by dansylcadaverine), the absence of a
1/C homolog among the BRV-encoded gene products
suggests that BRV has evolved a novel strategy for cell
attachment. How BRV mediates cell attachment is not
clear. Our inability to inhibit BRV infection using baboon
sera obtained from animals exposed to BRV was unex-
pected, especially since the sera clearly recognized all of
the obvious , , and  proteins of the virus (Fig. 2). A
recent report also failed to detect neutralizing antibodies
against BRV in five acute or convalescent sera samples
obtained from baboons infected with BRV (Leland et al.,
2000). Whichever viral proteins or capsid structures me-
diate BRV cell attachment, these receptor-binding enti-
ties do not elicit a strong neutralizing antibody response,
contrary to the situation with the 1/C proteins of other
orthoreoviruses. It is conceivable that the inability to
trigger a neutralizing humoral response might contribute
to the pathogenic potential of BRV. Additional studies of
BRV receptor recognition and immune interactions offer
promising avenues for investigating the pathogenicity of
this novel reovirus in nonhuman primates.
Interestingly, despite conspicuous similarities be-
tween the orthoreoviruses and aquareoviruses, there is
no 1/C equivalent present in the gene products of
aquareovirus (Attoui et al., 2002). In addition, the density
associated with 1 at the vertices of the MRV virion is
absent in image reconstructions of aquareovirus (Shaw
et al., 1996). It may be that both BRV and aquareovirus
have evolved a cell attachment strategy that is indepen-
dent of the need for a 1/C equivalent. Further investi-
gation of BRV cell attachment may offer additional in-
sights into a diversity of reovirus receptor interactions.
MATERIALS AND METHODS
Viruses and cells
BRV was isolated from the brain tissue of a baboon
with meningoencephalomyelitis (Duncan et al., 1995) and
was obtained from Julia Hiliard (Southwest Foundation
for Biomedical Research, San Antonio, TX). The virus was
plaque purified and high titer stocks were grown in
African green monkey (Vero) cells as previously de-
scribed (Duncan et al., 1995). Mammalian reovirus sero-
type 3 strain Dearing was obtained from Patrick Lee
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(University of Calgary). The Vero cells were purchased
from the ATCC (CCL-81) and maintained at 37°C in a 5%
CO2 atmosphere, grown in medium 199 with Earle’s salts
containing 5% heat-inactivated fetal bovine serum (FBS)
and 100 units of penicillin and streptomycin per milliliter.
Antibodies
Serum from six baboons exhibiting reactivity with BRV-
specific antigens, including a serum sample from a con-
valescent BRV-infected encephalitic baboon, was kindly
donated by Julia Hiliard (Southwest Foundation for Bio-
medical Research). The generation and specificity of the
rabbit polyclonal antisera raised against the BRV p16 and
p15 proteins has been described previously (Dawe and
Duncan, 2002).
Cloning
The cDNA cloning and sequencing of the BRV S-class
dsRNA genome segments have been described previ-
ously (Duncan, 1999), as has the subcloning of the indi-
vidual p15 and p16 ORFs of the S4 genome segment into
the pcDNA3 vector (Dawe and Duncan, 2002).
Radiolabeled cell lysates
Vero cells were infected with BRV at a multiplicity of
infection of 5 PFU/cell in medium containing 1% FBS. To
prepare radiolabeled cell lysates, uninfected or BRV-
infected monolayers were labeled 12 h postinfection for
1 h with 100 Ci [3H]leucine (Amersham Pharmacia Bio-
tech) per milliliter leucine-free medium, prepared from
the MEM Select-Amine kit (Life Technologies) according
to the manufacturer’s instructions. Radiolabeled mono-
layers were then rinsed three times with phosphate-
buffered saline (PBS; 140 mM NaCl, 2.5 mM KCl, 10 mM
Na2HPO4, and 2 mM KH2PO4) and lysed in cold RIPA
buffer (50 mM Tris–HCl, pH 8; 150 mM NaCl, 1 mM EDTA,
1% IGEPAL; 0.5% sodium deoxycholate; and 0.1% SDS)
containing protease inhibitors (Sigma; 200 nM aprotinin,
1 M leupeptin, and 1 M pepstatin). Cell lysates were
harvested and the nuclei pelleted, 1 min at 13,000 g in a
bench-top microfuge.
Radiolabeled BRV
To prepare radiolabeled BRV, infected monolayers
were labeled 10 h postinfection for 2 h with 100 Ci
[3H]leucine per milliliter leucine-free medium, then
chased with 1.2 g/mL leucine for an additional 2 h.
Monolayers were rinsed three times with cold PBS,
scraped from the tissue culture dishes, and passed
through a 26.5-gauge syringe needle 10 times. Since BRV
is unstable in CsCl, virus was purified by extraction and
differential centrifugation. Briefly, cellular debris was re-
moved by centrifugation (20 min at 10,000 g) and the
virus-containing supernatant was pelleted through a
2-mL sucrose cushion (30% sucrose in medium) for 1 h at
27,000 rpm in an SW 40 rotor (Beckman). Concentrated
BRV pellets were resuspended in medium and used as
is, or further extracted with freon or 1% Triton-X 100 plus
RNase A (50 g/mL) before repelleting through a su-
crose cushion.
To establish the relative concentrations of BRV virus
particles and the extent of removal of p16 and NS from
these particles following extraction with freon or Triton
X-100 plus RNase, the protein profiles of the various radio-
labeled virus preparations were examined by SDS–PAGE
and fluorography. The intensities of the three -class pro-
teins (number of pixels in a constant area) that comigrated
as a single band on a 15% acrylamide gel were scanned
and quantified using the Molecular Analyst software (v.2.1.2)
and the GelDoc 1000 system (Bio-Rad). Twofold dilutions of
the various BRV particle preparations and multiple expo-
sures were used to ensure that the fluorograms were in the
linear exposure range of the X-ray film. The BRV particle
preparations were then diluted to equivalent particle con-
centrations based on the relative concentrations of the
-class proteins.
In vitro transcription and translation
BRV p16 uncapped transcripts were synthesized from
XhoI-linearized pcDNA3 plasmids using bacteriophage
T7 RNA polymerase. MRV-3 S1 uncapped transcripts
were synthesized from a HindIII-linearized pGem-4Z
plasmid using bacteriophage SP6 RNA polymerase. All
transcription reactions were performed using 1 g tem-
plate DNA, 2.5 mM NTPs, and 125 units polymerase, and
incubated 2 h at 37°C. All transcription reagents were
obtained from Life Technologies Inc. RNA (250 ng per 50
L reaction) was translated in the presence of
[3H]leucine (1 Ci per 50 L reaction) using nuclease-
treated rabbit reticulocyte lysates (Promega) according
to the instructions provided by the manufacturer.
Cell-binding assay
The cell-binding assay was based on the procedure
previously described for MRV 1 (Lee et al., 1981). Con-
fluent Vero cell monolayers in six-well plates (Falcon)
were washed once with PBS and the S100 fractions from
radiolabeled BRV-infected cell lysates, or radiolabeled in
vitro translated BRV p16, BRV NS, and MRV-3 1, con-
taining 5 mg/mL BSA and 1.2 g/mL leucine, were added
to the wells. The plates were incubated at 4°C with
intermittent rocking for 1 h, after which the supernatant
was removed and the monolayers were washed five
times with PBS. The cells were lysed with cold RIPA
buffer containing protease inhibitors, harvested, and
mixed with protein sample buffer (Laemmli, 1970) prior to
analysis of the radiolabeled cell-bound proteins by SDS–
PAGE using 15% polyacrylamide gels and fluorography
(Bonner, 1984).
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Immune precipitation
Aliquots of radiolabeled in vitro translated protein (1/10
translation reaction), cell lysates, or BRV (200,000 cpm)
were immune precipitated in RIPA buffer for 1 h using a
1:100 dilution of anti-p15, anti-p16, baboon sera, or nor-
mal rabbit sera. Immune complexes were recovered us-
ing fixed Staphylococcus aureus cells (Harlow and Lane,
1988), washed extensively with RIPA buffer, and released
by boiling in SDS protein sample buffer (Laemmli, 1970)
prior to SDS–PAGE using 15% polyacrylamide gels and
fluorography (Bonner, 1984).
Plaque reduction
BRV (250 PFU) was preincubated with equal volumes
of either anti-BRV serum from a convalescent baboon,
anti-p16 serum, or normal rabbit serum. After 2.5 h shak-
ing at room temperature, samples were diluted 10-fold
and used to infect Vero cell monolayers in six-well plates
for 1 h with intermittent rocking. Infected monolayers
were rinsed three times with warm PBS and overlaid with
medium containing 5% FBS and 2% agar. Three days
postinfection, the cells were fixed with 10% formaldehyde
in PBS and stained with crystal violet in 50% ethanol, and
the visible plaques counted.
Cell staining
Vero cell monolayers grown in six-well plates were trans-
fected with pcDNA3-encoded BRV genes (S4, S4 ORF1, and
S4 ORF2) using Lipofectamine (Life Technologies) and
stained 18 h later with Wright-Giemsa stain (Diff-Quik) ac-
cording to the manufacturer’s instructions (VWR Scientific)
to visualize cell nuclei and polykaryon formation. To detect
BRV-infected foci, 10 h postinfection Vero cell monolayers
were fixed and permeabilized with methanol prior to immu-
nocytochemical staining. Monolayers were preblocked with
PBS containing 25 g/mL whole-goat IgG (Jackson Immu-
noResearch) and infected foci detected using primary rab-
bit polyclonal antiserum specific for p16, diluted 1:100. Foci
were visualized using a secondary goat anti-rabbit F(ab)2
conjugated to alkaline phosphatase (Jackson ImmunoRe-
search, diluted 1:1000) according to standard protocols
(Harlow and Lane, 1988). Images of stained cells were
visualized on a Nikon Diaphot inverted microscope at 200
magnification and captured using computer software Im-
age-Pro Plus (v.4.0).
Quantification of infected foci
The relative infectivities of different BRV preparations
(concentrated, extracted, and adjusted to equal particle
concentrations as described above) were compared and
quantified using a focus forming assay. Serial twofold
dilutions of the different standardized virus particle prep-
arations were used to inoculate Vero cell monolayers,
and the infected foci were detected by immunostaining
as described above. The stained monolayers were ob-
served using Nikon Diaphot inverted microscope at
100 magnification and the average number of infected
foci in five random fields were quantified using computer
software Image-Pro Plus (v.4.0) as described previously
(O’Hara et al., 2001).
Analysis of BRV endocytic uptake
To confirm that BRV enters cells by endocytosis, dan-
sylcadaverine was used to inhibit the endocytic entry
pathway, as previously reported for ARV (Duncan, 1996).
Vero cells were pretreated for 1 h with 0.1 mM dansylca-
daverine prior to infection with BRV. The virus inoculum
containing dansylcadaverine was incubated with cells
for 3 h at 37°C to permit virus attachment and entry. The
residual inoculum and inhibitor were then removed; cells
were overlaid with fresh medium, and infected cells were
incubated at 37°C. The infected cell lysates were Gi-
emsa stained at 12 h postinfection to detect virus-in-
duced syncytium formation (an indirect assessment of
virus infection) or harvested at 72 h postinfection and
processed for quantification of infectious progeny virus
production by plaque assay, as described above. Titers
were compared to parallel infected cell cultures that
were mock treated with the inhibitor.
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